Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis

NCT03337165 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Russian Academy of Medical Sciences